Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 11, 2022

BUY
$194.69 - $268.46 $147,964 - $204,029
760 New
760 $203,000
Q4 2021

Jan 18, 2022

SELL
$223.92 - $287.77 $170,179 - $218,705
-760 Closed
0 $0
Q3 2021

Oct 21, 2021

SELL
$282.99 - $369.05 $28,299 - $36,905
-100 Reduced 11.63%
760 $215,000
Q2 2021

Jul 21, 2021

SELL
$259.0 - $414.71 $85,211 - $136,439
-329 Reduced 27.67%
860 $298,000
Q1 2021

Apr 22, 2021

BUY
$242.95 - $284.63 $71,427 - $83,681
294 Added 32.85%
1,189 $333,000
Q4 2020

Jan 20, 2021

SELL
$236.26 - $355.63 $8,269 - $12,447
-35 Reduced 3.76%
895 $219,000
Q3 2020

Oct 21, 2020

BUY
$264.77 - $305.71 $15,886 - $18,342
60 Added 6.9%
930 $264,000
Q2 2020

Jul 14, 2020

SELL
$258.66 - $342.55 $25,866 - $34,255
-100 Reduced 10.31%
870 $233,000
Q4 2019

Jan 15, 2020

BUY
$220.06 - $304.07 $15,404 - $21,284
70 Added 7.78%
970 $288,000
Q1 2019

Apr 22, 2019

BUY
$216.71 - $338.96 $43,342 - $67,792
200 Added 28.57%
900 $212,000
Q4 2018

Jan 22, 2019

SELL
$278.5 - $352.75 $27,850 - $35,275
-100 Reduced 12.5%
700 $211,000
Q3 2018

Oct 05, 2018

SELL
$293.51 - $383.83 $155,560 - $203,429
-530 Reduced 39.85%
800 $282,000
Q2 2018

Aug 13, 2018

BUY
$257.52 - $306.91 $342,501 - $408,190
1,330 New
1,330 $386,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Boenning & Scattergood, Inc. Portfolio

Follow Boenning & Scattergood, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.